{"id":46555,"date":"2022-07-26T09:01:50","date_gmt":"2022-07-26T07:01:50","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/smoore-opens-first-pmta-testing-laboratory-in-china\/"},"modified":"2022-07-26T09:01:50","modified_gmt":"2022-07-26T07:01:50","slug":"smoore-opens-first-pmta-testing-laboratory-in-china","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/smoore-opens-first-pmta-testing-laboratory-in-china\/","title":{"rendered":"SMOORE Opens First PMTA Testing Laboratory in China"},"content":{"rendered":"
\n

SHENZHEN, China–(BUSINESS WIRE)–SMOORE, the world’s largest vape manufacturer, today announced that is has opened China\u2019s first non-clinical full-scale testing laboratory for Premarket Tobacco Product Applications (PMTA).\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nA PMTA is an application that must be reviewed and approved by the Food and Drug Administration (FDA) before a new nicotine product can be legally marketed in the United States. It must also provide scientific data that demonstrates a product is appropriate for the protection of public health.\n<\/p>\n

\nThe laboratory, opened and operated by SMOORE\u2019s Analysis, Testing and Safety Assessment Center, provides all non-clinical evidence required to bring a new nicotine product to market, including material safety, HPHCs (hazardous components and potentially hazardous components), and toxicology testing.\n<\/p>\n

\nThis is the first PMTA testing laboratory to open in China, and will allow SMOORE and its flagship brand FEELM, the world\u2019s leading closed vape system solution provider, to further improve the safety of their products, and help the brands they work with to successfully pass PMTA certification.\n<\/p>\n

\nPrior to SMOORE opening its new laboratory, any vaping companies that wanted to enter the US would need to use third-party partners to complete their PMTA testing, which can be a costly and time-consuming process. With the new China facility, FEELM\u2019s brand partners can more easily complete their PMTA certification and improve their accessibility to the US market.\n<\/p>\n

\nDr Long, the director of SMOORE\u2019s new Safety Assessment Center, said:\n<\/p>\n

\n\u201cThe FDA is very concerned about HPHCs and has set out a list of 33 substances which must be tested for.\n<\/p>\n

\n\u201cOur new laboratory can do all this and more, and has the capacity to test for 37 substances; we are the only facility in China whose testing capabilities covers the full range of HPHCs substances.\u201d\n<\/p>\n

\nThe laboratory tests against a world-leading new database of HPHCs, developed by SMOORE, and derived from international toxicity databases including the US Environmental Protection Agency (EPA).\n<\/p>\n

\nAdvanced computational toxicology software is also used to predict for unknown and potentially hazardous ingredients not included in these databases, further increasing SMOORE\u2019s safety assessments.\n<\/p>\n

\nSince establishing its first research institute in 2017, SMOORE has continued to lead the industry in evidence-based research. Its Safety Assessment Center has raised safety standards to medical grade, and works to constantly review product safety.\n<\/p>\n

\nA total of eight products have been approved for marketing by the FDA, many of which are manufactured by SMOORE, demonstrating that the FDA approves of the processes and testing mechanisms deployed in SMOORE\u2019s new laboratory in China.\n<\/p>\n

\nSMOORE is now working with its brand partners and FEELM clients to expand its testing and to provide greater support for product design and is issuing the relevant safety reports.\n<\/p>\n

\nSMOORE is determined to become the driving force behind supporting brands in their engagement with the FDA and other regulatory agencies, empowering them to enter more overseas markets.\n<\/p>\n

\nNOTES FOR EDITORS<\/b>\n<\/p>\n

\nFor more information on the PMTA process: fda.gov\/tobacco-products\/market-and-distribute-tobacco-product\/premarket-tobacco-product-applications<\/a>\n<\/p>\n

\nAbout FEELM:<\/b>\n<\/p>\n

\nAs a flagship tech brand belonging to SMOORE, FEELM is the world\u2019s leading closed vape system solution provider. Based on the world’s leading Ceramic Coil Heating Technology, FEELM combines authentic Flavor Reproduction Technology with innovative electronics technology, bringing ultimate sensation and premium vaping experience.\n<\/p>\n

\nAbout SMOORE:<\/b>\n<\/p>\n

\nSMOORE is a global leader in offering vaping technology solutions, including manufacturing vaping devices, and vaping components for HNB products on an ODM basis, with advanced R&D technology, strong manufacturing capacity, wide-spectrum product portfolio and diverse customer base.\n<\/p>\n

\nAccording to Frost & Sullivan, SMOORE is the world\u2019s largest vaping device manufacturer in terms of revenue, accounting for 22.8% of the total global market share in 2021<\/b>. Its global market share is bigger than the sum of those listed from No.2 to No.5.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFor more information or journalist queries, please contact Tommy Gilchrist on 0044 7388 110 679 or via tommy@davidroach.co.uk<\/a>.\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SHENZHEN, China–(BUSINESS WIRE)–SMOORE, the world’s largest vape manufacturer, today announced that is has opened China\u2019s first non-clinical full-scale testing laboratory for Premarket Tobacco Product Applications (PMTA). A PMTA is an application that must be reviewed and approved by the Food and Drug Administration (FDA) before a new nicotine product can be legally marketed in the … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46555","6":"format-standard","7":"category-industry"},"yoast_head":"\nSMOORE Opens First PMTA Testing Laboratory in China - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/smoore-opens-first-pmta-testing-laboratory-in-china\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SMOORE Opens First PMTA Testing Laboratory in China - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SHENZHEN, China–(BUSINESS WIRE)–SMOORE, the world’s largest vape manufacturer, today announced that is has opened China\u2019s first non-clinical full-scale testing laboratory for Premarket Tobacco Product Applications (PMTA). A PMTA is an application that must be reviewed and approved by the Food and Drug Administration (FDA) before a new nicotine product can be legally marketed in the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/smoore-opens-first-pmta-testing-laboratory-in-china\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-26T07:01:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220725005966\/en\/1524065\/21\/SMOORE_Lab.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/smoore-opens-first-pmta-testing-laboratory-in-china\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/smoore-opens-first-pmta-testing-laboratory-in-china\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"SMOORE Opens First PMTA Testing Laboratory in China\",\"datePublished\":\"2022-07-26T07:01:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/smoore-opens-first-pmta-testing-laboratory-in-china\\\/\"},\"wordCount\":651,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/smoore-opens-first-pmta-testing-laboratory-in-china\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220725005966\\\/en\\\/1524065\\\/21\\\/SMOORE_Lab.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/smoore-opens-first-pmta-testing-laboratory-in-china\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/smoore-opens-first-pmta-testing-laboratory-in-china\\\/\",\"name\":\"SMOORE Opens First PMTA Testing Laboratory in China - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/smoore-opens-first-pmta-testing-laboratory-in-china\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/smoore-opens-first-pmta-testing-laboratory-in-china\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220725005966\\\/en\\\/1524065\\\/21\\\/SMOORE_Lab.jpg\",\"datePublished\":\"2022-07-26T07:01:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/smoore-opens-first-pmta-testing-laboratory-in-china\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/smoore-opens-first-pmta-testing-laboratory-in-china\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/smoore-opens-first-pmta-testing-laboratory-in-china\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220725005966\\\/en\\\/1524065\\\/21\\\/SMOORE_Lab.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220725005966\\\/en\\\/1524065\\\/21\\\/SMOORE_Lab.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/smoore-opens-first-pmta-testing-laboratory-in-china\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SMOORE Opens First PMTA Testing Laboratory in China\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SMOORE Opens First PMTA Testing Laboratory in China - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/smoore-opens-first-pmta-testing-laboratory-in-china\/","og_locale":"en_US","og_type":"article","og_title":"SMOORE Opens First PMTA Testing Laboratory in China - Pharma Trend","og_description":"SHENZHEN, China–(BUSINESS WIRE)–SMOORE, the world’s largest vape manufacturer, today announced that is has opened China\u2019s first non-clinical full-scale testing laboratory for Premarket Tobacco Product Applications (PMTA). A PMTA is an application that must be reviewed and approved by the Food and Drug Administration (FDA) before a new nicotine product can be legally marketed in the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/smoore-opens-first-pmta-testing-laboratory-in-china\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-26T07:01:50+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220725005966\/en\/1524065\/21\/SMOORE_Lab.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/smoore-opens-first-pmta-testing-laboratory-in-china\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/smoore-opens-first-pmta-testing-laboratory-in-china\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"SMOORE Opens First PMTA Testing Laboratory in China","datePublished":"2022-07-26T07:01:50+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/smoore-opens-first-pmta-testing-laboratory-in-china\/"},"wordCount":651,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/smoore-opens-first-pmta-testing-laboratory-in-china\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220725005966\/en\/1524065\/21\/SMOORE_Lab.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/smoore-opens-first-pmta-testing-laboratory-in-china\/","url":"https:\/\/pharma-trend.com\/en\/smoore-opens-first-pmta-testing-laboratory-in-china\/","name":"SMOORE Opens First PMTA Testing Laboratory in China - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/smoore-opens-first-pmta-testing-laboratory-in-china\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/smoore-opens-first-pmta-testing-laboratory-in-china\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220725005966\/en\/1524065\/21\/SMOORE_Lab.jpg","datePublished":"2022-07-26T07:01:50+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/smoore-opens-first-pmta-testing-laboratory-in-china\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/smoore-opens-first-pmta-testing-laboratory-in-china\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/smoore-opens-first-pmta-testing-laboratory-in-china\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220725005966\/en\/1524065\/21\/SMOORE_Lab.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220725005966\/en\/1524065\/21\/SMOORE_Lab.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/smoore-opens-first-pmta-testing-laboratory-in-china\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"SMOORE Opens First PMTA Testing Laboratory in China"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46555","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46555"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46555\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46555"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46555"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46555"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}